We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WING icon
276
Wingstop
WING
$3.06B
$190K 0.01%
+1,497
New +$210K
VRTX icon
277
PUT
Vertex Pharmaceuticals
VRTX
$135B
$189K 0.01%
5,200
-2,300
-31% -$505K
ARBGW
278
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$189K 0.01%
+198,514
New +$300K
TWNI.U
279
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
$180K 0.01%
+18,250
New +$184K
CHPT icon
280
PUT
ChargePoint
CHPT
$162M
$175K 0.01%
+5,680
New +$3.83M
GM icon
281
CALL
General Motors
GM
$78.4B
$170K 0.01%
+30,000
New +$1.59M
RICE.WS
282
DELISTED
Rice Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise pr
RICE.WS
$170K 0.01%
+114,651
New +$257K
ARGX icon
283
PUT
argenx
ARGX
$53.9B
$169K 0.01%
3,400
-1,600
-32% -$506K
BSX icon
284
CALL
Boston Scientific
BSX
$74.4B
$168K 0.01%
+209,500
New +$7.93M
SGEN
285
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
$168K 0.01%
+10,000
New +$1.61M
CLAA.U
286
DELISTED
Colonnade Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
CLAA.U
$167K 0.01%
+16,970
New +$169K
SFIX
287
CALL
Stitch Fix
SFIX
$506M
$162K 0.01%
+138,500
New +$9.75M
TVRD
288
CALL
Tvardi Therapeutics
TVRD
$22.2M
$162K 0.01%
+2,761
New +$1.89M
HWCC
289
DELISTED
Houston Wire & Cable Company
HWCC
$157K 0.01%
+30,000
New +$115K
BMRN icon
290
PUT
BioMarin Pharmaceuticals
BMRN
$13.4B
$153K 0.01%
15,000
-9,200
-38% -$752K
APSG.WS
291
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$153K 0.01%
+121,237
New +$235K
SRSAW
292
DELISTED
Sarissa Capital Acquisition Corp. Warrants
SRSAW
$150K 0.01%
+100,000
New +$209K
ACAD icon
293
PUT
Acadia Pharmaceuticals
ACAD
$5.08B
$148K 0.01%
+7,500
New +$330K
CLVR
294
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$146K 0.01%
473
AVAN.WS
295
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$145K 0.01%
138,080
+113,080
+452% +$199K
NSTD.U
296
DELISTED
Northern Star Investment Corp. IV Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTD.U
$139K 0.01%
+13,992
New +$140K
AGIO icon
297
CALL
Agios Pharmaceuticals
AGIO
$1.96B
$137K 0.01%
20,900
+10,900
+109% +$540K
RIGL icon
298
Rigel Pharmaceuticals
RIGL
$775M
$137K 0.01%
+4,000
New +$158K
CONXW
299
DELISTED
CONX Corp. Warrant
CONXW
$137K 0.01%
111,555
+79,263
+245% +$140K
KWAC.WS
300
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$137K 0.01%
+258,266
New +$199K

Similar funds

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.